Team:UNA Honduras/references.html
Menu
HOME
TEAM
PROJECT
DESCRIPTION
IMMUNOLOGY OF DENGUE
EXPERIMENTS AND PROTOCOLS
RESULTS
PARTS
NOTEBOOK
ATTRIBUTIONS
COLLABORATIONS
HUMAN PRACTICES
PUBLIC OUTREACH
LAWS & REGULATION
ETHICS
MEDIA COVERAGE
SAFETY
ENTREPRENEURSHIP
GALLERY
REFERENCES
REFERENCES
Acosta, Carmen; Cordero, Ivonne, Gómez (2005): Biologia y métodos diagnosticos del dengue. In Rev Biomed 16 (2), pp. 113–137.
Aguilar, A. (2010). Organismos Geneticamente Modificados en Honduras Estado Actual. Tegucigalpa. Obtenido de: http://www.rallt.org/PAISES/LATINOAMERICA/HONDURAS/ESTADO%20ACTUAL%20
TRANSGENICOS%20HONDURAS.pdf
Amin, Nevis; Reyes, Fatima; Calero, Romero; Camacho, Frank; Acosta, Armando. (2013): Predicción de epítopos T y B de la proteína NS4b del virus dengue tipo 3. In VacciMonitor 22 (3), pp. 14–21. Available online at www.finlay.sld.cu/vaccimonitor.htm .
Beasley, D. W.; Aaskov, J. G. (2001): Epitopes on the dengue 1 virus envelope protein recognized by neutralizing IgM monoclonal antibodies. In Virology 279 (2), pp. 447–458. DOI: 10.1006/viro.2000.0721.
Bio FAB Group1, Baker D, Church G, Collins J, Endy D, Jacobson J, Keasling J, Modrich P, Smolke C, Weiss R. (2006): Engineering Life: Building a Fab for Biology. In SCIENTIFIC AMERICAN, INC. 294 (6), pp. 44–51.
Bowen, D.M., Lewis, J.A., Lu, W., Schein, C.H. (2012): Symplifying complex sequence information: A PCP-consensus protein binds antibodies against all four Dengue serotypes. In Vaccine 30, pp. 6081–6087.
Boysen,E., Muir, N.C., Dudley, D. (2011): Nanotechnology for Dummies. 2da edición. NJ.
Carlos Yábar V. (2003): Redalyc.Rol de las proteinas no estructurales en los eventos de replicación del ARN del virus dengue: propuesta de un modelo de replicación del ARN. In Rev Peru Med Exp Salud Publica 20 (1), pp. 51–57. Available online at www.redalyc.org.
Church, G. Regis E. Regenesis (2012): How Synthetic Biology Will Reinvent Nature and Ourselves. New York, NY.
Claverie, J.M. Motredame, C. (2007): Bioinformatics for Dummies. NJ.
Domingo, C., Gascón, J., Lópz-Vélez, R., Puente, S., Tenorio, A. (2004): Desarrollo de vacunas frente a las infecciones por dengue. In Revisiones, Vacunas 5 (24-32).
Comite de Bioseguridad de Espana, C. N. (2011). Biologia Sintetica. Barcelona-Lisboa: Comite de Bioetica de España. Obtenido de: http://www.comitedebioetica.es/documentacion/docs/es/CBE-CNECV_Informe_Biologia_Sintetica_24112011.pdf
 
Dominguez, A., Cardeñosa, N., Carmona, G., Barrabeig, I., Camps, N., Minguell, S., Tenorio, A., Salleras, L. (2003): Epidemiologìa y vacunas frente a las arbovirosis 4, pp. 86–94.
Doudna, Jennifer A.; Charpentier, Emmanuelle (2014): Genome editing. The new frontier of genome engineering with CRISPR-Cas9. In Science (New York, N.Y.) 346 (6213), p. 1258096. DOI: 10.1126/science.1258096.
Ect Group: Synthetic Biology: 10 key points for delegates. Available online at www.etcgroup.org .
Gordon Frierson. (2010). The Yellow Fever Vaccine: A History. YALE JOURNAL OF BIOLOGY AND MEDICINE, 83, 77–85.
Guy, Bruno; Barrere, Beatrice; Malinowski, Claire; Saville, Melanie; Teyssou, Remy; Lang, Jean (2011): From research to phase III: preclinical, industrial and clinical development of the Sanofi Pasteur tetravalent dengue vaccine. In Vaccine 29 (42), pp. 7229–7241. DOI: 10.1016/j.vaccine.2011.06.094.
Halstead, S.B., Thomas, S.J. Dengue Vaccines (2012): Chapter 44 in Vaccines in Development and New Vaccine Strategies. Washington, D.C.
Hiramatsu; K; al, et (1996): Mutational Analysis of a Neutralization Epitope on the Dengue Type 2 Virus (DEN2) Envelope Protein: Monoclonal Antibody Resistant DEN2/DEN4 Chimeras Exhibit Reduced Mouse Neurovirulence. In Virology 224 (0550), pp. 437–445.
Hoffman, Eric; Hanson, Jaydee; Thomas, Jim. (Eds.) (2012): The Principles for the Oversight of Synthetic Biology FINAL.
IGEM (2013). Zamorano. Available online at https://2014.igem.org/Team:Zamorano.
iGEM Giant Jamboree (2014). Cambridge, MA.
Isea, Raúl (2013): Mapeo computacional de epitopos de celulas presentes en el virus del dengue. B-cel epitopes mapping of dengue virus. In Rev. Instituto Nacional de Higiene "Rafael Rangel" 44 (1), pp. 25–29.
Karp, Gerald. (2005): Biología Celular y Molecular: Conceptos y Experimentos. 4ta.
Kistler, Kathryn E.; Vosshall, Leslie B.; Matthews, Benjamin J. (2015): Genome engineering with CRISPR-Cas9 in the mosquito Aedes aegypti. In Cell reports 11 (1), pp. 51–60. DOI: 10.1016/j.celrep.2015.03.009.
Jaschke, P. Roca, M. M. (2014): Desarrollo de un BiosensorBacterial para Detectar Contaminación de Cobre. Guía de Laboratorio. Stanford University – Zamorano.
 
Lanata, Claudio F.; Andrade, Teresa; Gil, Ana I.; Terrones, Cynthia; Valladolid, Omar; Zambrano, Betzana et al. (2012): Immunogenicity and safety of tetravalent dengue vaccine in 2-11 year-olds previously vaccinated against yellow fever: randomized, controlled, phase II study in Piura, Peru. In Vaccine 30 (41), pp. 5935–5941. DOI: 10.1016/j.vaccine.2012.07.043.
Lee, E., Weir, R. C., & Dalgarno, L. (1997). Changes in the dengue virus major envelope protein on passaging and their localization on the three-dimensional structure of the protein. Virology, 232(2), 281–290. doi:10.1006/viro.1997.8570
Logean, Antoine; Rognan, Didier (2002): Recovery of known T-cell epitopes by computational scanning of a viral genome. In Journal of Computer-Aided Molecular Design 16 (4), pp. 229–243. DOI: 10.1023/A:1020244329512.
Luria, S.E. Jr., Darnell, J.E., Baltimore, D., Campbell, A. (1978): General Virology. With assistance of John Wiley & Sons. 3ra. Hoboken, NJ.
Mac (Ed.) (2009): Synthetic biology. Scope, applications and implications. London: Royal Academy of Engineering.
Matsui, K., Gromowski, G. D., Li, L., & Barrett, A. D. T. (2010). Characterization of a dengue type-specific epitope on dengue 3 virus envelope protein domain III. The Journal of general virology, 91(Pt 9), 2249–2253. doi:10.1099/vir.0.021220-0
McArthur, Monica A.; Sztein, Marcelo B.; Edelman, Robert (2013): Dengue vaccines: recent developments, ongoing challenges and current candidates. In Expert review of vaccines 12 (8), pp. 933–953. DOI: 10.1586/14760584.2013.815412.
Messer, W. B., Alwis, R. de, Yount, B. L., Royal, S. R., Huynh, J. P., Smith, S. A., . . . Baric, R. S. (2014). Dengue virus envelope protein domain I/II hinge determines long-lived serotype-specific dengue immunity. Proceedings of the National Academy of Sciences of the United States of America, 111(5), 1939–1944. doi:10.1073/pnas.1317350111
Modis, Yorgo; Ogata, Steven; Clements, David; Harrison, Stephen. (2015): Variable Surface Epitopes in the Crystal Structure of Dengue Virus Type 3 Envelope Glycoprotein†. In JOURNAL OF VIROLOGY 79 (2), pp. 1223–1231.
Murray, T. (2012). La Etica y la Biologia Sintetica: Cuatro corrientes, tres informes. Barcelona: Fudacion Victor Grifols. Obtenido de: https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=1&cad=rja&uact=8&sqi=2&ved=0CB0QFjAAah
UKEwif1eDmy_THAhXJ8x4KHRokCi0&url=http%3A%2F%2Fwww.bcn.cl%2Fobtienearchivo%3Fid%3Ddocumentos%2F10221.1%2F46693%2F1%2Finforme5Eticaylabiolog%25C3%25ADasint%25C3%25A9tica.pdf&usg=AFQjCNF8mCNMM58y6WJt-YFEtaWKsFH-og&sig2=eblsNI89Grr67E7KQ41kpQ&bvm=bv.102537793,d.dmo
Newman MJ, Livingston B, McKinney DM, Chesnut RW, Sette A. 2002 T-lymphocyte epitope identification and their use in vaccine development for HIV-1. Front. Biosci. 7, d1503–d1515. doi:10.2741/newman
Poutou, Raul; Quevedo, Balkys; Córdoba, Henry; Sáenz, Homero; Barrera, Luis. (2005): Influencia de la fuente de carbono sobre la expresión de proteínas AOX1-reguladas en Pichia pastoris. In NOVA - PUBLICACIÓN CIENTÍFICA No. 3, pp. 1–120.
Prescott, L.M., Harley, J.P., Klein, D.A (1999): Microbiology. 4ta. Boston Burr Ridge IL.
Quiroga, Ana (2010): OPTIMIZACIÓN DEL CULTIVO DE ESCHERICHIA COLI PARA LA PRODUCCIÓN DE CUTINASAS RECOMBINANTES. With assistance of Maria Contreras. Santiago, Chile.
Rojas, W. (1988): Inmunología. 7ma. Medellín,     Colombia.
Salvador, Daniel; Santander, Angeles; Roldán, Mauricio; Valdez, Norma. (2012): Biología Sintética: diseñando sistemas biológicos con piezas genéticas. In BioTecnología 16 (1), pp. 11–20.
Sander, J. D., & Joung, J. K. (2014). CRISPR-Cas systems for editing, regulating and targeting genomes. Nature biotechnology, 32(4), 347–355. doi:10.1038/nbt.2842
Tours, Heber (Ed.): Microsoft Word - Manual de Practicas.docx.
SERNA.  (2007). Propuesta Marco Nacional Sobre Seguridad de la Biotecnologia. Tegucigalpa: DiBio. Obtenido de:  http://www.unep.org/biosafety/files/HNNBFrepSP.pdf
 
Secretaria  de Educacion. (2003). Sitemas educativos nacionales. Tegucigalpa: UNAH.  Obtenido de: http://www.oei.es/quipu/honduras/cap04.pdf
 
Schaar, Hilde M.; Wilschut, Jan C.; Smit, Jolanda M. (2009): Role of antibodies in controlling dengue virus infection. In Immunobiology 214 (7), pp. 613–629. DOI: 10.1016/j.imbio.2008.11.008.
Schmindt, W. Charles (2010): Environmental Health Implications of a new field. In Focus on Synthetic Biology 118 (3).
Stainer, R.Y., Adelberg, E.A., Ingraham, J.L. (1983): General Microbiology. 4ta. London.
TB/HIV Research Lab., Brown University, Providence, RI 02912, USA. Hakima_Sbai@Brown.edu
Velandia, Myriam; Castellanos, Jaime. (2011): Virus del dengue: estructura y ciclo viral. In Infectio 15 (1), pp. 33–43.
Villanueva, C. J. (2011). Molecular Aspects Involved in the Immunogenicity against Viral Epitopes: An Immunoinformatic Perspective: Immunogenicity. Immunology and immune system disorders. Hauppauge, N.Y.: Nova Science.
Villar, Luis; Dayan, Gustavo Horacio; Arredondo-García, José Luis; Rivera, Doris Maribel; Cunha, Rivaldo; Deseda, Carmen et al. (2015): Efficacy of a tetravalent dengue vaccine in children in Latin America. In The New England journal of medicine 372 (2), pp. 113–123. DOI: 10.1056/NEJMoa1411037.
Watson, J.D., Hopkins, N. H., Roberts, J.W., Steitz, J.A., Weiner, A.M. (1988): Molecular Biology of the Gene. 4ta. Menlo Park, CA.
Whitehorn, J., & Farrar, J. (2010). Dengue. British medical bulletin, 95, 161–173. doi:10.1093/bmb/ldq019
Yang, X., & Yu, X. (2009). An introduction to epitope prediction methods and software. Reviews in medical virology, 19(2), 77–96. doi:10.1002/rmv.602
Yauch, L.E., Shresta, S. (2014): Dengue Virus Vaccine Development. In Advances in Virus Research 88.
 
 
 
Database
National Center for Biotechnology Information, [en línea], (1988), Bethesda, Maryland, National Library of Medicine.
The Protein Data Bank, [en linea], (1971), at Brookhaven National Laboratory, U.S, Rutgers, The State University of New Jersey, San Diego Supercomputer Center (SDSC) and Skaggs School of Pharmacy and Pharmaceutical Sciences.
SWISS-MODELO: modelado de proteínas estructura terciaria y cuaternaria utilizando información evolutiva , [en linea], Instituto Suizo de Bioinformática Biozentrum , Universidad de Basilea.
 
Designed by Blue+ .
